| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5883042 | Clinical Lymphoma Myeloma and Leukemia | 2015 | 9 Pages |
Abstract
Treatment with ruxolitinib improved measures of metabolic and nutritional status of patients with intermediate-2 or high-risk MF.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Ruben A. Mesa, Srdan Verstovsek, Vikas Gupta, John O. Mascarenhas, Ehab Atallah, Timothy Burn, William Sun, Victor Sandor, Jason Gotlib,